Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TARCEVA vs TAZEMETOSTAT HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TARCEVA vs TAZEMETOSTAT HYDROBROMIDE: Safety Overview

Metric TARCEVA TAZEMETOSTAT HYDROBROMIDE
Total FAERS Reports 623 1,323
Deaths Reported 345 158
Death Rate 55.4% 11.9%
Hospitalizations 116 233
Average Patient Age 67.8 yrs 54.0 yrs
% Female Patients N/A 50.4%
FDA Approval Date N/A Jan 23, 2020
Manufacturer N/A Epizyme, Inc.
Route N/A ORAL
Marketing Status N/A Prescription